For example, ERCC2 gene mutations have been shown to indirectly increase the risk of SC (106, 107), and the Melanocortin receptor 1 (MC1R), which encodes melanocyte-stimulating hormone (MSH) receptors, has also been shown to be a risk factor for skin cancer (108). This evidence concerns the gene MC1R and skin cancer.